Formulation and Structural Optimisation of PVA-Fibre Biopolymer Composites for 3D Printing in Drug Delivery Applications
Polymers · 16.09.2025 · 17 (18) · 2502
DOI: 10.3390/polym17182502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polymers, online erschienen am 16.09.2025. Verfasst von Pattaraporn Panraksa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chiang Mai University, Thailand Science Research and Innovation.
Abstract (Originalsprache)
Additive manufacturing using fused deposition modelling (FDM) is increasingly explored for personalised drug delivery, but the lack of suitable biodegradable and printable filaments limits its pharmaceutical application. In this study, we investigated the influence of formulation and structural design on the performance of polyvinyl alcohol (PVA)-based filaments doped with theophylline anhydrous for 3D printing. To address the intrinsic brittleness and poor printability of PVA, cassava pulp-derived fibres—a sustainable and underutilised agricultural by-product—were incorporated together with polyethylene glycol (PEG 400), Eudragit® NE 30 D, and calcium stearate. The addition of fibres modified the mechanical properties of PVA filaments through hydrogen bonding, improving flexibility but increasing surface roughness. This drawback was mitigated by Eudragit® NE 30 D, which enhanced surface smoothness and drug distribution uniformity. The optimised composite formulation (P10F5E5T5) was successfully extruded and used to fabricate 3D-printed constructs. Release studies demonstrated that drug release could be modulated by pore geometry and construct thickness: wider pores enabled rapid Fickian diffusion, while narrower pores and thicker constructs shifted release kinetics toward anomalous transport governed by polymer swelling. These findings demonstrate, for the first time, the potential of cassava fibre as a functional additive in pharmaceutical FDM and provide a rational formulation–structure–performance framework for developing sustainable, geometry-tuneable drug delivery systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- School of Pharmacy, Monash University Malaysia, Subang Jaya 47500, Selangor Darul Ehsan, Malaysia.
- School of Pharmacy, University College London, London WC1N 1AX, UK.
- Division of Packaging Technology, School of Agro-Industry, Faculty of Agro-Industry, Chiang Mai University, Chiang Mai 50100, Thailand.
- Biomedical Engineering Institute, Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Mechanical and Aerospace Engineering, Brunel University London, Uxbridge UB8 3PH, UK.
ORCID-Profile: Pattaraporn Panraksa, Pensak Jantrawut, Xin Yi Teoh, Takron Chantadee, Suruk Udomsom, Bin Zhang
Förderung
- Chiang Mai University
- Thailand Science Research and Innovation
Zitieren
APA
Panraksa, P., Jantrawut, P., Teoh, X. Y., Sengtakdaed, K., Pornngam, P., Chaiwarit, T., Chantadee, T., Jantanasakulwong, K., Udomsom, S., & Zhang, B. (2025). Formulation and Structural Optimisation of PVA-Fibre Biopolymer Composites for 3D Printing in Drug Delivery Applications. Polymers, 17(18), 2502. https://doi.org/10.3390/polym17182502
Vancouver
Panraksa P, Jantrawut P, Teoh XY, Sengtakdaed K, Pornngam P, Chaiwarit T, et al. Formulation and Structural Optimisation of PVA-Fibre Biopolymer Composites for 3D Printing in Drug Delivery Applications. Polymers. 2025;17(18):2502. doi:10.3390/polym17182502
BibTeX
@article{Panraksa2025,
author = {Panraksa, Pattaraporn and Jantrawut, Pensak and Teoh, Xin Yi and Sengtakdaed, Krit and Pornngam, Ploynapat and Chaiwarit, Tanpong and Chantadee, Takron and Jantanasakulwong, Kittisak and Udomsom, Suruk and Zhang, Bin},
title = {Formulation and Structural Optimisation of PVA-Fibre Biopolymer Composites for 3D Printing in Drug Delivery Applications},
journal = {Polymers},
year = {2025},
volume = {17},
number = {18},
pages = {2502},
doi = {10.3390/polym17182502}
}
EUVIMED